← Open Payments lookup

YOBEL ASEFAW: Open Payments

NPI 1114624509 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,429 in 183 payments from 18 companies in 2025. Trend: 2023 $562 · 2024 $2,556 · 2025 $3,429

Food & beverage: $3,429
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.30$550
Neurocrine BioSciences, Inc.20$416
Alkermes, Inc.15$375
Teva Pharmaceuticals USA, Inc.14$310
ABBVIE INC.20$278
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$273
E.R. Squibb & Sons, L.L.C.10$230
Janssen Pharmaceuticals, Inc8$189
Vanda Pharmaceuticals Inc.7$183
Axsome Therapeutics, Inc.7$149

Products named: REXULTI, INGREZZA, ARISTADA, VRAYLAR, CAPLYTA, COBENFY, AUSTEDO XR, FANAPT.

Industry payments across NV — which companies pay providers there.